PRI's Focus on Health Care
View this email in your browser ([link removed])
[link removed]
PRI Webinar: Medicare for All and the COVID-19 Crisis with Sally C. Pipes
When: Wednesday, May 20, 2020 at 11 AM PST
Join PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes for a discussion on why “Medicare for All” would be the wrong solution for the U.S. to embark on to combat the coronavirus and other future health crises on Wednesday, May 20. She’ll also discuss bad ideas like a proposed “Buy America” mandate that would hinder the development of a COVID-19 vaccine and introducing price controls on pharmaceuticals, telehealth, licensing laws, and more.
Register here. . . ([link removed])
In war on coronavirus, we need more foreign doctors practicing in US
Fox News | Sally C. Pipes
May 4, 2020
The United States was suffering from a shortage of doctors long before the coronavirus landed on our shores. The pandemic has cast that shortage into even starker relief. Right now, we need every qualified doctor we can find – and that need will not go away after the pandemic ends.
Read more. . . ([link removed])
Majority don’t understand what ‘Medicare for all’ means
The Washington Examiner | Sally C. Pipes
May 2, 2020
Estimates from the left-leaning Urban Institute and the market-oriented Mercatus Center put the cost of “Medicare for all” at well over $32 trillion over 10 years. The Mercatus study says that even doubling all federal individual and corporate income tax receipts would be insufficient to cover that sum.
Read more. . . ([link removed])
PRI “Buy America” Brief Mentioned in National Review
Featured in Yahoo! Finance and National Review
April 28, 2020
A new report from the Pacific Research Institute provides more good news: China accounted for just 1 percent ($1.5 billion) and 18 percent ($1.2 billion) of finished pharmaceutical imports and APIs, respectively, into the United States in 2019, and “combined, the United States had a $1.6 billion trade surplus with China for these pharmaceutical products and ingredients.”
Read more. . . ([link removed])
Single Payer Poll Watch: Coronavirus Leads to Spike in Support
Right By the Bay Blog | Evan Harris
April 29, 2020
The latest PRI Single-Payer Poll Watch shows a sharp increase in single-payer health care support through April 2020. Favorability leaped roughly 10 points to 56.5 percent, according to the average of the four most recent polls. Opposition did increase from the March update, from 30 to 34 percent.
Read more. . . ([link removed])
Stupid Is As Stupid Does
American Greatness | Henry Miller, M.S., M.D. and Andrew Fillat
May 1, 2020
And real estate is immune to this viral infection, unless termites are found to be carriers.
Then there is the restriction on motor-boating, although sailing and rowing are permitted. Another odd requirement is that large stores must close off areas that display carpeting, flooring, furniture, gardening supplies, and paint. With many states requiring simply that total customer occupancy be controlled, why not just use that approach?
Read more. . . ([link removed])
[link removed]
Third PRI Drug Pricing Video Explains Drug Innovation Costs ([link removed])
The PRI Center for Medical Economics and Innovation released the third video ([link removed]) in its series about explaining drug innovation costs. Watch Professor Salvare take Pete Paystoomuch in a time machine to learn how drugs become cheaper after higher initial costs that incentivize innovation, going up the “prescription escalator” to learn why so much is spent on prescription drugs despite the mass use of cheaper generics.
============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.